GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WPD Pharmaceuticals Inc (XCNQ:WBIO) » Definitions » Shiller PE Ratio

WPD Pharmaceuticals (XCNQ:WBIO) Shiller PE Ratio : (As of May. 08, 2025)


View and export this data going back to 2008. Start your Free Trial

What is WPD Pharmaceuticals Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


WPD Pharmaceuticals Shiller PE Ratio Historical Data

The historical data trend for WPD Pharmaceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WPD Pharmaceuticals Shiller PE Ratio Chart

WPD Pharmaceuticals Annual Data
Trend Jan13 Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Dec20 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

WPD Pharmaceuticals Quarterly Data
Jul19 Oct19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of WPD Pharmaceuticals's Shiller PE Ratio

For the Biotechnology subindustry, WPD Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WPD Pharmaceuticals's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WPD Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where WPD Pharmaceuticals's Shiller PE Ratio falls into.


;
;

WPD Pharmaceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

WPD Pharmaceuticals's E10 for the quarter that ended in Sep. 2024 is calculated as:

For example, WPD Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0/127.2847*127.2847
=0.000

Current CPI (Sep. 2024) = 127.2847.

WPD Pharmaceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201407 -0.250 99.315 -0.320
201410 -0.375 99.473 -0.480
201501 0.250 98.209 0.324
201504 -0.014 99.710 -0.018
201507 -0.125 100.579 -0.158
201510 -0.023 100.500 -0.029
201601 -0.077 100.184 -0.098
201604 -0.030 101.370 -0.038
201607 -0.250 101.844 -0.312
201610 -0.375 102.002 -0.468
201701 -1.125 102.318 -1.400
201704 -0.625 103.029 -0.772
201707 -0.750 103.029 -0.927
201710 -1.000 103.424 -1.231
201801 -0.188 104.056 -0.230
201804 -0.250 105.320 -0.302
201807 -0.250 106.110 -0.300
201810 -0.250 105.952 -0.300
201901 -0.250 105.557 -0.301
201904 -0.109 107.453 -0.129
201907 -0.250 108.243 -0.294
201910 -0.124 107.927 -0.146
202003 -0.500 107.927 -0.590
202006 -0.500 108.401 -0.587
202009 -0.250 108.164 -0.294
202012 0.000 108.559 0.000
202103 -0.250 110.298 -0.289
202106 -0.250 111.720 -0.285
202109 -0.250 112.905 -0.282
202203 -0.250 117.646 -0.270
202206 -0.250 120.806 -0.263
202209 -0.250 120.648 -0.264
202212 1.250 120.964 1.315
202303 -0.008 122.702 -0.008
202306 -0.017 124.203 -0.017
202309 0.000 125.230 0.000
202312 0.000 125.072 0.000
202403 -0.035 126.258 -0.035
202406 -0.004 127.522 -0.004
202409 0.000 127.285 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


WPD Pharmaceuticals  (XCNQ:WBIO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


WPD Pharmaceuticals Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of WPD Pharmaceuticals's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


WPD Pharmaceuticals Business Description

Traded in Other Exchanges
Address
700-595 Burrard Street, Suite 401, Vancouver, BC, CAN, V7X 1S8
WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, virology, research, and development of medicinal products involving biological compounds and small molecules.
Executives
Constantine Carmichel Director

WPD Pharmaceuticals Headlines

No Headlines